News 2019

Deep Phosphoproteomics detects therapeutic targets for modulation by kinase inhibitors – published in PNAS

4/1/2019
​Dysregulation of signaling pathways in multiple sclerosis (MS) can be analyzed by phosphoproteomics in peripheral blood mononuclear cells (PBMCs).